The U.S. will begin sharing its entire AstraZeneca vaccine pipeline once the Covid-19 vaccine clears federal safety reviews, the White House told The Associated Press on Monday. Up to 60 million cans are expected to be available for export in the coming months.
The move greatly expands the Biden government’s efforts last month to share approximately 4 million doses of the vaccine with Mexico and Canada. The AstraZeneca vaccine is widely used around the world, but has not yet been approved by the US Food and Drug Administration.
The White House is increasingly confident that the three vaccines will be given in the US, especially after the Johnson & Johnson single-dose restart over the weekend. The U.S. has also been under increasing pressure in recent weeks to share more of its vaccine supply with the world as nations like India suffer devastating virus floods and others struggle to access doses needed to protect their most vulnerable populations.
Reading | 24 states are offering a free Covid-19 vaccine starting May 1st. Full list here
“Given the strong portfolio of vaccines the US already owns that have been approved by the FDA and the fact that the AstraZeneca vaccine is not approved for use in the US, we have the AstraZeneca vaccine here in the next Years don’t use months, “said Jeff Zients, White House Covid-19 coordinator. “So the US is looking into options to share the AstraZeneca cans with other countries as soon as they become available.”
More than 3 million people have died of Covid-19 worldwide, including more than 572,000 in the United States. The U.S. has vaccinated more than 53% of its adult population with at least one dose of its three approved vaccines from Pfizer, Moderna, and J&J and expects adequate coverage for the entire population by early summer.
Approximately 10 million doses of AstraZeneca vaccine have been made but have yet to be reviewed by the FDA to “meet product quality expectations,” Zients said, noting that the US regulator is recognized as the “gold standard” for safety around the world . This process could be completed in the next few weeks. About 50 million more cans are in various stages of production and could be shipped in May and June before FDA approval.
The US has yet to determine where the AstraZeneca cans should go, Zients said. Neighbors Mexico and Canada have asked the Biden government to share more doses while dozens of other countries are looking for supplies of the vaccine.
The AstraZeneca cans are being donated by the US government, which has signed a contract with the company for a total of 300 million cans – despite the company facing production problems.
More than 3 million people have died of Covid-19 worldwide, including more than 572,000 in the United States. The U.S. has vaccinated more than 53% of its adult population with at least one dose of its three approved vaccines from Pfizer, Moderna, and J&J and expects adequate coverage for the entire population by early summer.
Approximately 10 million doses of AstraZeneca vaccine have been made but have yet to be reviewed by the FDA to “meet product quality expectations,” Zients said, noting that the US regulator is recognized as the “gold standard” for safety around the world . This process could be completed in the next few weeks. About 50 million more cans are in various stages of production and could be shipped in May and June before FDA approval.
The US has yet to determine where the AstraZeneca cans should go, Zients said. Neighbors Mexico and Canada have asked the Biden government to share more doses while dozens of other countries are looking for supplies of the vaccine.
The AstraZeneca cans are being donated by the US government, which has signed a contract with the company for a total of 300 million cans – despite the company facing production problems.
إرسال تعليق